Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-21-033563
Filing Date
2021-06-22
Accepted
2021-06-22 16:31:29
Documents
2
Period of Report
2021-05-24
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea143024-8ka_citiuspharma.htm 8-K/A 31409
2 CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF CITIUS PHARMACEUTIC ea143024ex3-1_citiuspharma.htm EX-3.1 9067
  Complete submission text file 0001213900-21-033563.txt   41971
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 001-38174 | Film No.: 211035717
SIC: 2834 Pharmaceutical Preparations